Literature DB >> 9733895

Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

M Ahmed1, D S Lyles.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) functions in virus assembly and inhibits host-directed gene expression independently of other viral components. Experiments in this study were carried out to determine the ability of M protein to inhibit transcription directed by each of the three host RNA polymerases (RNA polymerase I [RNAPI], RNAPII, and RNAPIII). The effects of wild-type (wt) VSV, v6 (a VSV mutant isolated from persistently infected cells), and tsO82 viruses on poly(A)+ and poly(A)- RNA synthesis were measured by incorporation of [3H]uridine. v6 and tsO82 viruses, which contain M-gene mutations, had a decreased ability to inhibit synthesis of both poly(A)+ and poly(A)- RNA. Nuclear runoff analysis showed that VSV inhibited transcription of 18S rRNA and alpha-tubulin genes, which was dependent on RNAPI and RNAPII, respectively, but infection with wt virus enhanced transcription of 5S rRNA by RNAPIII. The effect of M protein alone on transcription by RNAPI-, RNAPII-, and RNAPIII-dependent promoters was measured by cotransfection assays. M protein inhibited transcription from RNAPI- and RNAPII-dependent promoters in the absence of other viral gene products. RNAPIII-dependent transcription of the adenovirus VA promoters was also inhibited by M protein. However, as observed during wt VSV infection, M protein enhanced endogenous 5S rRNA transcription, indicating that the inhibition of transcription by RNAPIII was dependent on the nature of the promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733895      PMCID: PMC110232     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

2.  Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

3.  Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus.

Authors:  L S Her; E Lund; J E Dahlberg
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

4.  Premature of chromosome condensation in a ts DNA- mutant of BHK cells.

Authors:  T Nishimoto; E Eilen; C Basilico
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

5.  The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.

Authors:  M C Ferran; J M Lucas-Lenard
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.

Authors:  M Ahmed; D S Lyles
Journal:  Virology       Date:  1997-10-27       Impact factor: 3.616

7.  Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells.

Authors:  P K Weck; R R Wagner
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

8.  Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.

Authors:  D S Lyles; M O McKenzie; M Ahmed; S C Woolwine
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

9.  Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.

Authors:  D S Lyles; M O McKenzie
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

10.  Role of temperature-sensitive mutants in persistent infections initiated with vesicular stomatitis virus.

Authors:  J S Youngner; E J Dubovi; D O Quagliana; M Kelly; O T Preble
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  57 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures.

Authors:  P P Chiou; C H Kim; P Ormonde; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Intranuclear degradation of nonsense codon-containing mRNA.

Authors:  Marc Bühler; Miles F Wilkinson; Oliver Mühlemann
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

5.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.

Authors:  R N Harty; M E Brown; J P McGettigan; G Wang; H R Jayakar; J M Huibregtse; M A Whitt; M J Schnell
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Authors:  Reena Ghildyal; Adeline Ho; Manisha Dias; Lydia Soegiyono; Phillip G Bardin; Kim C Tran; Michael N Teng; David A Jans
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.

Authors:  Brooke L Carey; Maryam Ahmed; Shelby Puckett; Douglas S Lyles
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection.

Authors:  Jim B Boonyaratanakornkit; Emmalene J Bartlett; Emerito Amaro-Carambot; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.